Is Luspatercept a New Option for Patients With MDS?

Dr. List discusses results from the MEDALIST trial in patients with transfusion-dependent myelodysplastic syndromes, which were presented as a plenary abstract at the 2018 ASH Annual Meeting.

SHARE